Butorphanol precipitates abstinence in morphine dependent rats.

Area of Science:

• Pharmacology
• Neuroscience
• Behavioral Science

Background:

• Opioid dependence is a major public health concern.
• Understanding opioid withdrawal is crucial for developing effective treatments.
• Butorphanol and naloxone are opioid receptor modulators with different pharmacological profiles.

Purpose of the Study:

• To investigate and compare the opioid withdrawal syndrome precipitated by butorphanol and naloxone in a rat model.
• To characterize the qualitative and quantitative differences in withdrawal behaviors induced by these two agents.

Main Methods:

• Continuous intracerebroventricular infusion of morphine to establish dependence in rats for three days.
• Challenge with butorphanol or naloxone to precipitate withdrawal.
• Observation and quantification of specific withdrawal behaviors (defecation, urination, teeth chattering, escape behavior, wet shake behavior).

Main Results:

• Butorphanol precipitated a withdrawal syndrome in morphine-dependent rats.
• The potency of butorphanol to induce withdrawal behaviors was 10-100 times less than naloxone on a molar basis.
• Wet shake behavior, a key feature of naloxone-precipitated withdrawal, was notably absent in butorphanol-challenged animals.

Conclusions:

• Butorphanol induces opioid withdrawal, but it is quantitatively less potent than naloxone.
• Qualitative differences exist between butorphanol- and naloxone-precipitated opioid withdrawal syndromes.
• These findings highlight distinct pharmacological actions of butorphanol and naloxone in the context of opioid dependence and withdrawal.